NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study of ONO-1110 in Patients With Postherpetic Neuralgia

NCT06708416

CompletedPhase 2

Sponsor: Ono Pharmaceutical Co., Ltd.

Conditions: Postherpetic Neuralgia

Interventions: ONO-1110, Placebo

Countries: Japan

To evaluate the efficacy and safety of ONO-1110 in Japanese patients with postherpetic neuralgia

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Japanese (both sexes)
* Age (at the time of informed consent): 18 years and older
* Outpatient
* Patients with persistent pain ≥3 months (90 days) after the onset of herpes zoster
* Patients who are considered capable of understanding the study procedures and completing the pain diary and questionnaires appropriately by the investigator (sub-investigator)

Exclusion Criteria:

* Patients who previously underwent neurodestruction or neurosurgical therapy for PHN
* Patients with pain other than PHN that may affect assessments in this study
* Patients with any skin condition related to the site of herpes zoster that may affect assessments in this study
* Patients with a past history of or concurrent neurologic diseases that may affect assessments in this study
* Patients with concurrent psychiatric diseases that may affect assessments in this study

Locations (31)

Aichi, Japan
Aichi, Japan
Fukuoka, Japan
Fukushima, Japan
Gifu, Japan
Hiroshima, Japan
Hokkaido, Japan
Hyōgo, Japan
Ibaraki, Japan
Kanagawa, Japan
Kanagawa, Japan
Kanagawa, Japan
Kanagawa, Japan
Kanagawa, Japan
Miyazaki, Japan
Miyazaki, Japan
Okinawa, Japan
Osaka, Japan
Osaka, Japan
Osaka, Japan
Ōita, Japan
Shizuoka, Japan
Shizuoka, Japan
Tokyo, Japan
Tokyo, Japan
Tokyo, Japan
Tokyo, Japan
Tokyo, Japan
Tokyo, Japan
Tokyo, Japan
+ 1 more on CT.gov